Volume 22, Number 12—December 2016
CME ACTIVITY - Research
Electrolyte and Metabolic Disturbances in Ebola Patients during a Clinical Trial, Guinea, 2015
Table 4
Death risk category (predicted), % | Total no. patients (column %) | No. deaths observed (row %) | No. deaths predicted (row %) |
---|---|---|---|
0–4.9 | 28 (36.4) | 1 (3.6) | 0.4 (1.5) |
5.0–19.9 | 14 (18.2) | 1 (7.1) | 1.7 (12.3) |
20.0–49.9 | 11 (14.3) | 4 (36.4) | 3.7 (34.0) |
50.0–79.9 | 7 (9.1) | 4 (57.1) | 4.4 (63.5%) |
80.0–100 | 17 (22.1) | 17 (100.0) | 16.7 (98.1) |
*One recruited patient was excluded because of a missing Ct value. Ct, cycle threshold; POC, point-of-care.
†POC+ model includes 3 POC measurements (blood creatinine, calcium, and hemoglobin) plus the cycle threshold value of the diagnostic Ebola PCR result and the age of the patient.
Page created: November 17, 2016
Page updated: November 17, 2016
Page reviewed: November 17, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.